Cephalon Defends Narcolepsy Drug From Generics At Trial
By Lance Duroni ( July 18, 2012, 8:51 PM EDT) -- Cephalon Inc. squared off with a host of generic-drug makers in Delaware federal court on Wednesday in a patent infringement suit aiming to block generic versions of its narcolepsy drug Nuvigil from hitting the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.